| Time | Topic |
|---|---|
| 7:00 a.m. | Registration/Continental Breakfast |
| 7:45 a.m. | Welcome Announcements |
| Lymphoproliferative Disease | |
| 8:00 a.m. | Diffuse Large Cell Lymphoma Stephen M. Ansell, M.D., Ph.D. |
| 8:30 a.m. | Follicular Lymphoma Craig B. Reeder, M.D. |
| 9:00 a.m. | Chronic Lymphocytic Leukemia (CLL) Prognostics and Therapy Neil E. Kay, M.D. |
| 9:30 a.m. | Who to Refer to Bone Marrow Transplantation James L. Slack, M.D. |
| 10:00 a.m. | Q & A Panel Discussion |
| 10:30 a.m. | Break |
| Thrombosis | |
| 10:45 a.m. | Making Sense of New Anticoagulants David Garcia, M.D. |
| 11:15 a.m. | Spectrum of Impact of Tyrosine Kinase Inhibition in MPNs and CML Ruben A. Mesa, M.D. |
| 11:45 p.m. | Keynote Speakers: Individualize Cancer Care – A Reality in 2013? Mitesh J. Borad, M.D. and Keith Stewart, MB., ChB. |
| 12:30 p.m. | Q & A Panel Discussion |
| 12:45 p.m. | Lunch |
| Lung Cancer | |
| 1:30 p.m. | Approach to Anaplastic Lymphoma Kinase and Other Genomically-Directed Therapy in Metastatic Lung Cancer Helen J. Ross, M.D. |
| 2:00 p.m. | Strategies for Maintenance Therapy in Metastatic Non-Small Cell Lung Cancer Harshita R. Paripati, M.D. |
| 2:30 p.m. | Q & A Panel Discussion |
| 2:45 p.m. | Break |
| Gastrointestinal | |
| 3:00 p.m. | "Neoadjuvant" Therapy for Initially Unresectable Localized Pancreas Cancer Thorvardur R. Halfdanarson, M.D. |
| 3:30 p.m. | Minimally-Invasive Surgery for Esophagus Cancer Dawn E. Jaroszewski, M.D. |
| 4:00 p.m. | HIPEC Therapy for Peritoneal Malignancies Nabil Wasif, M.D. |
| 4:30 p.m. | Q & A Panel Discussion |
| 5:00 p.m. | Adjourn |
| 5:15 p.m. | Reception |
